financetom
Business
financetom
/
Business
/
EPR Properties Insider Sold Shares Worth $369,095, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EPR Properties Insider Sold Shares Worth $369,095, According to a Recent SEC Filing
Nov 4, 2025 8:25 AM

11:11 AM EST, 11/04/2025 (MT Newswires) -- Gregory E Zimmerman, Executive Vice President & Chief Investment Officer, on November 03, 2025, sold 7,500 shares in EPR Properties ( EPR ) for $369,095. Following the Form 4 filing with the SEC, Zimmerman has control over a total of 73,877 common shares of the company, with 73,877 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1045450/000172234625000007/xslF345X05/wk-form4_1762272487.xml

Price: 50.29, Change: +0.08, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apellis Pharmaceuticals Q3 Loss Narrows, Revenue Gains -- Shares Fall Pre-Bell
Apellis Pharmaceuticals Q3 Loss Narrows, Revenue Gains -- Shares Fall Pre-Bell
Nov 6, 2024
08:23 AM EST, 11/05/2024 (MT Newswires) -- Apellis Pharmaceuticals ( APLS ) reported a Q3 net loss Tuesday of $0.46 per diluted share, narrowing from a loss of $1.17 a year earlier. Analysts polled by Capital IQ expected a loss of $0.31. Total revenue for the quarter ended Sept. 30 was $196.8 million, up from $110.4 million a year earlier....
Broadridge Financial profit beats estimates on strength in global technology unit
Broadridge Financial profit beats estimates on strength in global technology unit
Nov 6, 2024
Nov 5 (Reuters) - Fintech firm Broadridge Financial beat Wall Street estimates for first-quarter profit on Tuesday, helped by resilient demand in its global technology business. WHY IT'S IMPORTANT Broadridge provides investor communications and technology-driven services to banks, broker-dealers, asset managers and corporate issuers. A highly anticipated interest rate cut and a healthy economy boosted clients' confidence, fueling demand for...
Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings
Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings
Nov 6, 2024
(Reuters) - Contract drug manufacturer Catalent ( CTLT ), which is in the process of being acquired by Novo Holdings, posted a surprise first-quarter loss and revenue below Wall Street estimates on Tuesday. WHY IT'S IMPORTANT The company provides filling and packaging services for syringes and injection pens in sterile conditions, including for Danish drugmaker Novo Nordisk's popular weight-loss treatment...
Henry Schein beats quarterly profit estimates on lower costs
Henry Schein beats quarterly profit estimates on lower costs
Nov 6, 2024
Nov 5 (Reuters) - Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and slow recovery from a cyberattack it disclosed in October last year. The company, which supplies products such as dental implants and personal protective equipment (PPE), had faced disruptions in manufacturing and distribution units after...
Copyright 2023-2026 - www.financetom.com All Rights Reserved